1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. 𝕏 Posts
Discussion
1. Investment Snapshot
2. Metrics vs Peers
3. Capital Structure
4. Price Chart
5. What does Cerebras Systems Inc. do?
6. Valuation
7. Offer Terms
Discussion
Research report, target price, DCF and forensic scores are for subscribers. View plans
Symbol
CBRS
Listed on
2026-05-14
Sector
Information Technology
Subsector
Semiconductors & Semiconductor Equipment
Offer Price
$185.00
first filed $115.00–$125.00Shares Offered
30M
Shares Outstanding Pre-IPO
171.17M
171.17M
$23.3B
17.5%
Implied Upside vs Midpoint
Description
**Valuation Verdict:** The IPO-implied valuation screens aggressive versus Cerebras’ current revenue scale and typical peer multiples, so the setup looks skewed against new buyers until growth durability and profitability quality are clearer. The $24.6B RPO helps on demand visibility, but adjusted operating losses and incentive/contra-revenue mechanics that can dilute reported revenue support a Hold bias. **Catalyst Timeline:** The nearest tradable swing factor is float dynamics, including any overallotment that increases supply. Fundamental re-rating hinges on (1) proof of broader hyperscaler adoption and (2) clean execution on the WSE-3 production ramp over the next 12–24 months. **Growth & Margin Trajectory:** Backlog supports the growth narrative, but reported revenue and gross margin could turn choppier as contra-revenue programs and warrant-related dilution begin flowing through starting Q1 2026. 2025 net income alongside adjusted operating losses suggests accounting profitability is improving, but cash/operating profitability is not yet consistently demonstrated. **Governance & Operational Risk:** A sponsor-influenced offering structure and high customer concentration raise exposure to lockup/supply dynamics and a small number of large renewal or expansion decisions. Execution risk remains elevated given capital intensity and the need to scale production reliably for large AI workloads. **Scenario Targets:** Base case: modest scaling with margin recovery after contra-revenue effects normalize, implying meaningful downside versus the IPO-implied valuation (analyst fair value cited ~48% below market). Bull case: broad hyperscaler adoption plus margin expansion supports today’s valuation over a multi-year horizon. Bear case: continued contra-revenue/warrant dilution and slower TAM penetration drive multiple compression and material downside.
▼ More expensive than its peers on 2 of 2 valuation measures
| Metric | Value | Peer median | Among peers | Trend |
|---|---|---|---|---|
EV / revenue | 44.3x | 5.6x | ||
Price / earnings | >100x | 71.7x | ||
Revenue growth | 75.7% | 16.1% | ||
Gross margin | 39.0% | 60.4% | ||
Operating margin | -28.6% | -9.0% | ||
Net margin | 46.6% | -9.7% | ||
Rule of 40 | 47.1% | 7.8% | ||
Net cash / market cap | 3.0% | 3.0% | ||
Debt / equity | 0.00 | 0.00 | ||
9 premium metrics: DCF value / price, Growth the price needs: how common, Last 12 months vs full year and 6 more Unlock | ||||
Post-IPO economic shares by class, valued at the offer midpoint.
| Class | Shares | % Economic | Est. value |
|---|---|---|---|
Class A common stock (listed) 1 vote per share | 57.91M | 33.8% | $10.7B |
Redeemable Convertible Preferred Stock (various series) | 113.26M | 66.2% | $21.0B |
| Total economic shares | 171.17M | 100% | $31.7B |
No price history available yet for this perp.
The IPO-implied valuation screens aggressive versus Cerebras’ current revenue scale and typical peer multiples, so the setup looks skewed against new buyers until growth durability and profitability quality are clearer. The $24.6B RPO helps on demand visibility, but adjusted operating losses and incentive/contra-revenue mechanics that can dilute reported revenue support a Hold bias.
The nearest tradable swing factor is float dynamics, including any overallotment that increases supply. Fundamental re-rating hinges on (1) proof of broader hyperscaler adoption and (2) clean execution on the WSE-3 production ramp over the next 12–24 months.
Backlog supports the growth narrative, but reported revenue and gross margin could turn choppier as contra-revenue programs and warrant-related dilution begin flowing through starting Q1 2026. 2025 net income alongside adjusted operating losses suggests accounting profitability is improving, but cash/operating profitability is not yet consistently demonstrated.
A sponsor-influenced offering structure and high customer concentration raise exposure to lockup/supply dynamics and a small number of large renewal or expansion decisions. Execution risk remains elevated given capital intensity and the need to scale production reliably for large AI workloads.
Base case: modest scaling with margin recovery after contra-revenue effects normalize, implying meaningful downside versus the IPO-implied valuation (analyst fair value cited ~48% below market). Bull case: broad hyperscaler adoption plus margin expansion supports today’s valuation over a multi-year horizon. Bear case: continued contra-revenue/warrant dilution and slower TAM penetration drive multiple compression and material downside.
▲ Priced at $185.00, 54% above the midpoint of the first filed range ($115.00–$125.00, 2026-05-04).
Each filing is plotted ahead of the first trading day on the price chart.
| Filed | Form | Price range | Price | Shares offered | Deal size |
|---|---|---|---|---|---|
| 2026-05-04 | S-1/A | $115.00–$125.00 | — | 28,000,000 | $3.36B |
| 2026-05-11 | S-1/A | $150.00–$160.00 | — | 30,000,000 | $4.65B |
| 2026-05-14 | 424B4 | — | $185.00 | 30,000,000 | $5.55B |